Inhalative sedation using isoflurane compare to intravenous sedation in neuro critical care patients
Completed
- Conditions
- unselected neulogical critical care patients
- Registration Number
- DRKS00027950
- Lead Sponsor
- niversitätsklinikum Gießen und Marburg, Standort Giessen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Need for sedation, severe cerebral disease, treatment at the neurological intensive care unit
Exclusion Criteria
age below 18 years, pregnancy, allergies or contraindication to isoflurane or propfol
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of both sedation strategies in reaching the daily intended deep of sedation
- Secondary Outcome Measures
Name Time Method Comparison of both sedation strategies to: the kind of difference to the intended deep of sedation, time of mechanical ventilation, need for additional sedative medication, incidence of delirium, incidence of ventilator-associated pneumonia, varying pupil-diameter, functional outcome, mortality, influence of different neurological illnesses
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie isoflurane's neuroprotective effects in critical care patients compared to intravenous sedatives?
How does inhaled isoflurane sedation compare to intravenous midazolam or propofol in neurological ICU outcomes like delirium incidence?
Are specific biomarkers (e.g., GABA receptor subtypes, inflammatory cytokines) predictive of isoflurane response in neurocritical care?
What adverse events are associated with inhaled isoflurane versus intravenous sedation in DRKS00027950's neurological critical care cohort?
How do combination strategies of isoflurane with neuromuscular blockers impact sedation efficacy in traumatic brain injury patients?